Dopamine Dorsolateral Prefrontal Cortex Behavioural Flexibility
NCT ID: NCT03068884
Last Updated: 2018-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2017-03-01
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Two known neurobiological mechanisms which relate to BF performance are variation in dopamine (DA) and serotonin (SE) function. One particular brain regions which has been heavily implicated in BF is the prefrontal cortex (PFC), with the dorsolateral PFC receiving a largely DA innervation and the dorsomedial PFC a SE input. Studies have demonstrated that damage to parts of PFC including the orbitofrontal cortex (OFC), for example, impairs reversal learning (a form of BF) whereas lesions of the dorsolateral PFC affect attentional set-shifting (another measure of BF).
In humans, putative augmentation of DA efflux via administration of the DA and norepinephrine precursor tyrosine has been shown to improve task-switching performance, and inhibitory control suggesting a causal role of DA in regulating BF. Similarly, putative depletion of serotonin neurotransmission via tryptophan depletion procedures has been shown to reduce the BOLD response during performance monitoring and increase perseverative behaviour.
One important strategy (in humans) to observe whether the PFC is causally involved in BF performance, is by reversible electrical stimulation of the PFC, so that PFC cells could be inhibited or excited while a participant is performing a BF task. In recent years, several laboratories have taken advantage of a relatively new technology known as transcranial direct current stimulation (tDCS) to study the relationship between brain function and behaviour. Using this technique, increases or decreases in cortical excitability are partly determined by the polarity of the stimulation; increases occur under the anode electrode whereas decreases occur under the negatively charged cathode.
Using this approach, several studies have shown that anodal and cathodal stimulation over the PFC can have a number of effects on BF performance, with general improvements during anodal stimulation and impairments during cathodal. If this is the case, one important step that remains to be understood is whether dopamine and serotonin are causally related to these outcomes when neurons of the dLPFC/dMPFC are either excited or inhibited via tDCS.
Thus, the specific novelty of this study rests in combining a psychopharmacological approach (i.e. tyrosine/tryptophan loading) with selective neuroanatomical (i.e. dorsolateral/dorsomedial prefrontal cortex) inhibition of cells via tDCS while participants are performing BF tasks. By doing so, we will be able to establish whether increased dopaminergic/serotonergic output to the PFC is a necessary requirement for BF performance.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Transcranial Direct Current Stimulation on Postural Control
NCT03759132
Use of Noninvasive Brain Stimulation in Parkinson's Disease
NCT01113086
Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
NCT06883266
Modulation of Cognitive Control Via Transcranial Continuous Electrical Stimulation of Additional Motor Areas in Parkinson's Patients
NCT04897633
Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease
NCT06301282
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tdcs sham
L-Tyrosine
Administration of 2 grams tyrosine
Cellulose (placebo)
Administration of 2 grams cellulose
Placebo
Cathodal Transcranial direct current stimulation
Cathodal transcranial direct current stimulation over the dorsolateral prefrontal cortex
Transcranial direct current stimulation (sham)
Sham tDCS
Tdcs cathodal
L-Tyrosine
Administration of 2 grams tyrosine
Cellulose (placebo)
Administration of 2 grams cellulose
Tyrosine
Cathodal Transcranial direct current stimulation
Cathodal transcranial direct current stimulation over the dorsolateral prefrontal cortex
Transcranial direct current stimulation (sham)
Sham tDCS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cathodal Transcranial direct current stimulation
Cathodal transcranial direct current stimulation over the dorsolateral prefrontal cortex
L-Tyrosine
Administration of 2 grams tyrosine
Transcranial direct current stimulation (sham)
Sham tDCS
Cellulose (placebo)
Administration of 2 grams cellulose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In good health
* Agrees to fast overnight prior to testing
Exclusion Criteria
* Presence of damaged or diseased skin on your face and scalp, or a sensitive scalp
* A history of alcohol or drug addiction, or severe psychiatric illness
* Taking drugs which may lower seizure threshold (i.e. epilepsy)
* In a state of pregnancy
* Having slept less than 6 hours the night before testing
* A history of migraine or headaches
* A history of taking antidepressants
* A history of taking tyrosine supplements
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheffield Hallam University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luca Aquili, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Sheffield Hallam University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Psychology laboratories
Sheffield, Yorkshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SheffieldHallamAquili2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.